Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease

14 May 2019

Abstract excerpt

The molecular scalpel of clustered regularly interspersed short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) technology may be sharp enough to begin cutting the genes implicated in inflammatory bowel disease (IBD) and consequently decrease the 6.3 billion dollar annual financial healthcare burden in the treatment of IBD. For the past few years CRISPR technology has drastically revolutionized DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Innovation and Socioeconomic Development
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31143069
DOI: 10.3748/wjg.v25.i18.2177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel diseasePMID 31143069Read ↗

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancerSemantic proximity Read ↗

Advances in CRISPR-Cas technology and its applications: revolutionising precision medicineSemantic proximity Read ↗

CRISPR/Cas9: the Jedi against the dark empire of diseasesSemantic proximity Read ↗

Genome Editing Using CRISPR-Cas9 and Autoimmune Diseases: A Comprehensive ReviewSemantic proximity Read ↗

Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applicationsSemantic proximity Read ↗

CRISPR/Cas gene therapy.Semantic proximity Read ↗

Progress and Perspective of CRISPR‐Cas9 Technology in Translational MedicineSemantic proximity Read ↗

CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseasesSemantic proximity Read ↗

CRISPR/Cas9: a powerful tool in colorectal cancer researchSemantic proximity Read ↗

Validation of a CRISPR/cas9-based technology platform for examining specific immune gene functions in an experimental murine model of IBDSemantic proximity Read ↗

CRISPR-mediated genome editing and human diseasesSemantic proximity Read ↗

What rheumatologists need to know about CRISPR/Cas9.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.